부산대학교 도서관

Krickeberg N; Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany.; Rammensee HG; Institute of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen, Germany, Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Schilbach K; Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Amorelli G; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; University of Tübingen, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen, Germany.; Rabsteyn A; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Maier CP; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, Center for Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Trautner F; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Holzer U; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Schäfer JF; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Department for Diagnostic and Interventional Radiology, University Hospital, Tuebingen, Germany.; Ebinger M; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Handgretinger R; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; Nahnsen S; Quantitative Biology Center (QBiC) Tübingen, University of Tübingen, Tübingen, Germany.; Rammensee HG; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Lang P; Department of Hematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital, Tuebingen, Germany.; University of Tübingen, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, University of Tuebingen, Tuebingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Wang J; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China. Electronic address: ustcwj@ustc.edu.cn.; Qiu Y; Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.; Marti Z; Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland; Cellerys AG, Wagistrasse 21, 8952 Schlieren, Switzerland.; Li F; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China; Institute of Health and Medicine, Hefei Comprehensive National Science Center, 230061 Hefei, China.; Wacker M; Department of Peptide-Based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, 72076 Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72076 Tübingen, Germany.; Oldrati P; Cellerys AG, Wagistrasse 21, 8952 Schlieren, Switzerland.; Mühlenbruch L; Department of Peptide-Based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, 72076 Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72076 Tübingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, 72076 Tübingen, Germany.; Jin L; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China.; Zhang H; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China; Institute of Health and Medicine, Hefei Comprehensive National Science Center, 230061 Hefei, China.; Xu W; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China.; Li T; State Key Laboratory of Immune Response and Immunotherapy, Department of Neurology, The First Affiliated Hospital of USTC, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, 230001 Hefei, China; Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, 230022 Hefei, China.; Roschitzki B; Functional Genomics Center Zurich, Swiss Federal Institute of Technology (ETHZ) and University of Zurich (UZH), Winterthurerstrasse 190, 8057 Zurich, Switzerland.; Faigle W; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; Institut Curie, PSL University, Inserm U932, Immunity and Cancer, 75005 Paris, France.; Liu Y; Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology (SUAT), 518107 Shenzhen, China.; Nguyen JT; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA.; Lee JH; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA.; Haunerdinger V; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, 8032 Zurich, Switzerland.; Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, 8032 Zurich, Switzerland.; Momburg F; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Bauer J; Department of Peptide-Based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, 72076 Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72076 Tübingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, 72076 Tübingen, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72076 Tübingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, 72076 Tübingen, Germany; Institute of Immunology, University of Tübingen, 72076 Tübingen, Germany.; Sospedra M; Cellerys AG, Wagistrasse 21, 8952 Schlieren, Switzerland; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.; Magliozzi R; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.; Reynolds R; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.; Walz J; Department of Peptide-Based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, 72076 Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, 72076 Tübingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, 72076 Tübingen, Germany; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Martin R; Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland; Cellerys AG, Wagistrasse 21, 8952 Schlieren, Switzerland; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland; Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institute, Center for Molecular Medicine, 17177 Stockholm, Sweden. Electronic address: roland.martin@uzh.ch.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Heitmann JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Maringer Y; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Jung S; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Wacker M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Hackenbruch C; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Polster M; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Marconato M; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Bauer J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Zwick M; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany.; Baur AS; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany; CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.; Lehmann A; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg, Germany.; Krolla C; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg, Germany.; Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Köhler N; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg, Germany.; Denk M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany.; Zieschang L; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany.; Kammer C; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Hoenisch-Gravel N; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Richter M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany.; Oezbek MT; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Wirths S; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Dengler A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany.; Dubbelaar ML; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Pumptow M; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany.; Martus P; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany.; Brüggemann M; Department of Hematology and Oncology, University Hospital Schleswig-Holstein Campus, Kiel, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany.; Walz JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany. Electronic address: juliane.walz@med.uni-tuebingen.de.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Bertrand L; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Nelde A; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Ramirez BC; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Hatin I; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Arbes H; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; François P; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Demais S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Labaronne E; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; ADLIN Science, Evry-Courcouronnes, France.; Decimo D; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.; Guiguettaz L; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; Grégoire S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Bet A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Beauclair G; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Gross A; IRIM, UMR 9004, CNRS, Université de Montpellier, Montpellier, France.; Ziegler MC; Leibniz Institute of Virology, Hamburg, Germany.; Pereira M; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Jeger-Madiot R; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Verdier Y; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.; Vinh J; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.; Cardinaud S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Vaccine Research Institute (VRI), INSERM-U955 (IMRB) Équipe 16, Université Paris-Est Créteil (UPEC), Créteil, France.; Graff-Dubois S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Esclatine A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Gouttefangeas C; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Altfeld M; Leibniz Institute of Virology, Hamburg, Germany.; Hocqueloux L; Centre Hospitalier Universitaire d'Orléans, Orléans, France.; Samri A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Autran B; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Lambotte O; Université Paris Saclay, Inserm, CEA, AP-HP, UMR1184 IDMIT, Department of Internal Medicine & Clinical Immunology, Bicêtre Hospital, Le Kremlin-Bicêtre, Bicêtre, France.; Rammensee HG; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Ricci EP; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; Walz J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076, Tübingen, Germany.; Namy O; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. olivier.namy@i2bc.paris-saclay.fr.; Moris A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. arnaud.moris@i2bc.paris-saclay.fr.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France. arnaud.moris@i2bc.paris-saclay.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

Bertrand L; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Nelde A; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Ramirez BC; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Hatin I; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Arbes H; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; François P; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Demais S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Labaronne E; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; ADLIN Science, Evry-Courcouronnes, France.; Decimo D; CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.; Guiguettaz L; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; Grégoire S; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Bet A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Beauclair G; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Gross A; IRIM, UMR 9004, CNRS, Université de Montpellier, Montpellier, France.; Ziegler MC; Leibniz Institute of Virology, Hamburg, Germany.; Pereira M; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Jeger-Madiot R; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Verdier Y; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.; Vinh J; ESPCI Paris, PSL University, Spectrométrie de Masse Biologique et Protéomique, CNRS UAR2051, Paris, France.; Cardinaud S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Vaccine Research Institute (VRI), INSERM-U955 (IMRB) Équipe 16, Université Paris-Est Créteil (UPEC), Créteil, France.; Graff-Dubois S; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Esclatine A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France.; Gouttefangeas C; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Altfeld M; Leibniz Institute of Virology, Hamburg, Germany.; Hocqueloux L; Centre Hospitalier Universitaire d'Orléans, Orléans, France.; Samri A; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Autran B; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.; Lambotte O; Université Paris Saclay, Inserm, CEA, AP-HP, UMR1184 IDMIT, Department of Internal Medicine & Clinical Immunology, Bicêtre Hospital, Le Kremlin-Bicêtre, Bicêtre, France.; Rammensee HG; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Ricci EP; Laboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, 46 allée d'Italie F-69364, Lyon, France.; Walz J; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, 72076, Tübingen, Germany.; Institute of Immunology, University of Tübingen, 72076, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, 72076, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076, Tübingen, Germany.; Namy O; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. olivier.namy@i2bc.paris-saclay.fr.; Moris A; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91190, Gif-sur-Yvette, France. arnaud.moris@i2bc.paris-saclay.fr.; Sorbonne Université, Inserm U1135, CNRS ERL 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France. arnaud.moris@i2bc.paris-saclay.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Hamza H; Institute for Immunology, University of Tübingen, Tübingen, Germany.; Virology Laboratory, Environmental Research Division, National Research Centre, Giza, Egypt.; Ghosh M; Institute for Immunology, University of Tübingen, Tübingen, Germany.; Löffler MW; Institute for Immunology, University of Tübingen, Tübingen, Germany.; Institute for Clinical and Experimental Transfusion Medicine, Medical Faculty of Tübingen, Tübingen, Germany.; Centre for Clinical Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Rammensee HG; Institute for Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence CMFI (EXC2124) 'Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany.; Planz O; Institute for Immunology, University of Tübingen, Tübingen, Germany.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

Jargosch M; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Kuruvila J; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Scala E; Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Dermatology and Venereology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Grosch J; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Eigemann J; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Department of Dermatology and Allergy, LMU Hospital, Munich, Germany.; Wasserer S; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Lekiashvili S; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Trautwein N; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Kowalewski DJ; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Böhner A; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Köseoglu Y; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Hillig C; Department of Computational Health, Institute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.; Department of Mathematics, Technical University of Munich, Munich, Germany.; Thomas J; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Lauffer F; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Department of Dermatology and Allergy, LMU Hospital, Munich, Germany.; Schmidt-Weber CB; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Center of Lung Research (DZL), Neuherberg, Germany.; Menden MP; Department of Computational Health, Institute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.; Department of Biochemistry & Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia.; Walz JS; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Kaesler S; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Eyerich S; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Blank S; ZAUM-Center of Allergy and Environment, Technical University of Munich, School of Medicine and Health & Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; Rammensee HG; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Biedermann T; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Eyerich K; Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Dermatology and Venereology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Kurgyis Z; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Freudenmann LK; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Garzorz-Stark N; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Dermatology and Venereology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

Maia A; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Schuhmacher J; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Nadalin S; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.; Königsrainer A; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Thiel K; Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.; Department of General, Visceral and Thoracic Surgery, Oberschwabenklinik gGmbH, St. Elisabethen-Klinikum, Ravensburg, Germany.; Nelde A; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Institute of Immunology, Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Zinser RS; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Schroeder C; Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Heidelberg, Germany.; Mattern S; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.; Singer S; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.; Bösmüller H; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.; Rammensee HG; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Heidelberg, Germany.; Löffler MW; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany Markus.Loeffler@uni-tuebingen.de cecile.gouttefangeas@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Heidelberg, Germany.; Institute for Clinical and Experimental Transfusion Medicine (IKET), University Hospital Tübingen, Tübingen, Germany.; Gouttefangeas C; Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany Markus.Loeffler@uni-tuebingen.de cecile.gouttefangeas@uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Heidelberg, Germany.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Jung S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Wacker M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Maringer Y; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Nelde A; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Bauer J; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Denk M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Hoenisch-Gravel N; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Richter M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Oezbek MT; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Dubbelaar ML; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Bilich T; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Pumptow M; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany.; Martus P; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany.; Illerhaus G; Department of Hematology, Oncology and Palliative Care, Katharinenhospital Stuttgart, Stuttgart, Germany.; Denzlinger C; Department of Oncology, Hematology and Palliative Care, Marienhospital Stuttgart, Stuttgart, Germany.; Steinbach F; Department of Hematology, Oncology and Palliative Care, Robert-Bosch-Krankenhaus, Stuttgart, Germany.; Aulitzky WE; Department of Hematology, Oncology and Palliative Care, Robert-Bosch-Krankenhaus, Stuttgart, Germany.; Müller MR; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Dörfel D; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Wyss N; Institute of Immunobiology.; Berner F; Institute of Immunobiology.; Walter V; Department of Dermatology, University Hospital Tübingen.; Jochum AK; Institute of Immunobiology.; Institute of Pathology.; Purde MT; Institute of Immunobiology.; Abdou MT; Institute of Immunobiology.; Sinnberg T; Department of Dermatology, University Hospital Tübingen.; iFIT Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies,'.; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Hofmeister K; Department of Dermatology, University Hospital Tübingen.; Pop OT; Institute of Immunobiology.; Hasan Ali O; Institute of Immunobiology.; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Bauer J; iFIT Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies,'.; Department of Peptide-based Immunotherapy, Institute of Immunology, University Hospital Tübingen, and.; Cheng HW; Institute of Immunobiology.; Lütge M; Institute of Immunobiology.; Klümper N; Institute for Experimental Oncology.; Center for Integrated Oncology Cologne/Bonn, and.; Department of Urology, University Hospital Bonn, Bonn, Germany.; Diem S; Department of Oncology and Hematology.; Kosaloglu-Yalcin Z; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.; Zhang Y; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Sellmer L; Department of Medicine V, University Hospital, and.; Comprehensive Pneumology Center Munich, German Center for Lung Research, Munich, Germany.; Macek B; Quantitative Proteomics, Interfaculty Institute of Cell Biology, Faculty of Science.; Karbach J; Department of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany.; König D; Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel, Basel, Switzerland.; Läubli H; Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel, Basel, Switzerland.; Zender L; iFIT Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies,'.; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, University of Tübingen, Tübingen, Germany.; German Cancer Research Consortium, partner site Tübingen, German Cancer Research Center, Heidelberg, Germany.; Meyer BS; Research Unit Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Hamburg, Germany.; Driessen C; Department of Oncology and Hematology.; Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Jochum W; Institute of Pathology.; Amaral T; Skin Cancer Center, Department of Dermatology, and.; Heinzerling L; Department of Dermatology, Ludwig Maximilian University of Munich, Munich, Germany.; Cozzio A; Department of Dermatology, and.; Hegazy AN; Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany.; Deutsches Rheuma-Forschungszentrum, ein Institut der Leibniz-Gemeinschaft, Berlin, Germany.; Schneider T; Department of Pneumology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Brutsche MH; Department of Pneumology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.; Department of Pathology, University of California, San Diego, La Jolla, California.; Lenz TL; Research Unit Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Hamburg, Germany.; Walz J; iFIT Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies,'.; Department of Peptide-based Immunotherapy, Institute of Immunology, University Hospital Tübingen, and.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium and German Cancer Research Center, partner site Tübingen, Tübingen, Germany.; Rammensee HG; iFIT Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies,'.; Institute of Immunology.; German Cancer Consortium and German Cancer Research Center, partner site Tübingen, Tübingen, Germany.; Früh M; Department of Oncology and Hematology.; Department of Oncology, University of Bern, Bern, Switzerland.; Jäger E; Department of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany.; Becher B; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; and.; Tufman A; Department of Medicine V, University Hospital, and.; Comprehensive Pneumology Center Munich, German Center for Lung Research, Munich, Germany.; Nuñez N; Facultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Universidad Nacional de Córdoba y Centro de Investigaciones en Bioquímica Clínica e Inmunología, Córdoba, Argentina.; Joerger M; Department of Oncology and Hematology.; Flatz L; Institute of Immunobiology.; Department of Dermatology, and.; Department of Dermatology, University Hospital Tübingen.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE

Abou Kors T; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Meier M; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Mühlenbruch L; Department of Immunology, Institute for Cell Biology, Eberhard Karls University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Eberhard Karls University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.; Betzler AC; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Core Facility Immune Monitoring, Ulm University Medical Center, Ulm, Germany.; Oliveri F; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Bens M; Core Facility Next Generation Sequencing, Leibniz Institute on Aging - Fritz Lipmann Institute, Jena, Germany.; Thomas J; Cancer Sciences Unit, University of Southampton, Faculty of Medicine, Southampton, United Kingdom.; Kraus JM; Institute of Medical Systems Biology, Faculty of Medicine, Ulm University, Ulm, Germany.; Doescher J; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Department of Otolaryngology, Augsburg University Hospital, Augsburg, Germany.; von Witzleben A; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Hofmann L; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Ezic J; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Huber D; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Benckendorff J; Institute of Pathology, Ulm University Medical Center, Ulm, Germany.; Barth TFE; Institute of Pathology, Ulm University Medical Center, Ulm, Germany.; Greve J; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Schuler PJ; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Surgical Oncology Ulm, i2SOUL Consortium, Ulm, Germany.; Brunner C; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Core Facility Immune Monitoring, Ulm University Medical Center, Ulm, Germany.; Blackburn JM; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Hoffmann TK; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Surgical Oncology Ulm, i2SOUL Consortium, Ulm, Germany.; Ottensmeier C; Institute of Systems, Molecular and Integrative Biology, Liverpool Head and Neck Center, University of Liverpool, Faculty of Medicine, Liverpool, United Kingdom.; Kestler HA; Institute of Medical Systems Biology, Faculty of Medicine, Ulm University, Ulm, Germany.; Surgical Oncology Ulm, i2SOUL Consortium, Ulm, Germany.; Rammensee HG; Department of Immunology, Institute for Cell Biology, Eberhard Karls University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.; Walz JS; Department of Peptide-based Immunotherapy, Eberhard Karls University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Laban S; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Surgical Oncology Ulm, i2SOUL Consortium, Ulm, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Bichmann L; Center for Systems and Engineering Immunology, Yale University, New Haven, Connecticut, USA leon.bichmann@yale.edu.; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Marcu A; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Genentech, San Francisco, California, USA.; Kowalewski DJ; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Freudenmann LK; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Backert L; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Mühlenbruch L; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University Hospital Tübingen, Baden-Württemberg, Germany.; Lübke M; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Wagner P; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Obstetrics and Gynecology, University Hospital of Tübingen, University of Tübingen, Tübingen, Germany.; Engler T; Obstetrics and Gynecology, University Hospital of Tübingen, University of Tübingen, Tübingen, Germany.; Matovina S; Obstetrics and Gynecology, University Hospital of Tübingen, University of Tübingen, Tübingen, Germany.; Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, University Hospital Zurich, Zurich, Switzerland.; Martin R; Neuroimmunology and MS Research, Institute of Experimental Immunology, University of Zurich, Zürich, ZH, Switzerland.; Moch H; Pathology, University Hospital Zurich, Zurich, Switzerland.; Regli L; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland.; Neuroscience Center Zurich (ZNZ), University of Zurich, Zürich, Switzerland.; Weller M; Neuroscience Center Zurich (ZNZ), University of Zurich, Zürich, Switzerland.; Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital Zurich, Zürich, Switzerland.; Löffler MW; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.; Walz JS; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University Hospital Tübingen, Baden-Württemberg, Germany.; Kohlbacher O; Applied Bioinformatics, University of Tübingen, Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics, University Hospitals Tubingen, Tübingen, Germany.; Röst H; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.; Rammensee HG; Interfaculty Institute for Cell Biology and Immunology, University of Tübingen, Tübingen, Germany.; Neidert MC; Neuroscience Center Zurich (ZNZ), University of Zurich, Zürich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St.Gallen, HOCH Health Ostschweiz, St. Gallen, SG, Switzerland.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Wermke M; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany.; Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chatterjee M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.; Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Holderried TAW; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.; Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reshef R; Columbia University Medical Center, New York, NY, USA.; Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Alsdorf W; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Wetzko K; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; Brossart P; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.; Aslan K; Immatics Biotechnologies GmbH, Tübingen, Germany.; Backert L; Immatics Biotechnologies GmbH, Tübingen, Germany.; Bunk S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Fritsche J; Immatics Biotechnologies GmbH, Tübingen, Germany.; Gulde S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hengler S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hossain MB; Immatics US, Inc., Houston, TX, USA.; Hukelmann J; Immatics Biotechnologies GmbH, Tübingen, Germany.; Kalra M; Immatics US, Inc., Houston, TX, USA.; Krishna D; Immatics US, Inc., Houston, TX, USA.; Kursunel MA; Immatics Biotechnologies GmbH, Tübingen, Germany.; Maurer D; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mayer-Mokler A; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mendrzyk R; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mohamed A; Immatics US, Inc., Houston, TX, USA.; Pozo K; Immatics US, Inc., Houston, TX, USA.; Satelli A; Immatics US, Inc., Houston, TX, USA.; Letizia M; Immatics Biotechnologies GmbH, Tübingen, Germany.; Schuster H; Immatics Biotechnologies GmbH, Tübingen, Germany.; Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany.; Wagner C; Immatics Biotechnologies GmbH, Tübingen, Germany.; Rammensee HG; Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany.; Reinhardt C; Immatics Biotechnologies GmbH, Tübingen, Germany.; Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany.; Walter S; Immatics US, Inc., Houston, TX, USA.; Weinschenk T; Immatics Biotechnologies GmbH, Tübingen, Germany.; Luke JJ; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Britten CM; Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

Wermke M; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany.; Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chatterjee M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.; Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Holderried TAW; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.; Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Reshef R; Columbia University Medical Center, New York, NY, USA.; Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Alsdorf W; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Wetzko K; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; Brossart P; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.; Aslan K; Immatics Biotechnologies GmbH, Tübingen, Germany.; Backert L; Immatics Biotechnologies GmbH, Tübingen, Germany.; Bunk S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Fritsche J; Immatics Biotechnologies GmbH, Tübingen, Germany.; Gulde S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hengler S; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany.; Hossain MB; Immatics US, Inc., Houston, TX, USA.; Hukelmann J; Immatics Biotechnologies GmbH, Tübingen, Germany.; Kalra M; Immatics US, Inc., Houston, TX, USA.; Krishna D; Immatics US, Inc., Houston, TX, USA.; Kursunel MA; Immatics Biotechnologies GmbH, Tübingen, Germany.; Maurer D; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mayer-Mokler A; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mendrzyk R; Immatics Biotechnologies GmbH, Tübingen, Germany.; Mohamed A; Immatics US, Inc., Houston, TX, USA.; Pozo K; Immatics US, Inc., Houston, TX, USA.; Satelli A; Immatics US, Inc., Houston, TX, USA.; Letizia M; Immatics Biotechnologies GmbH, Tübingen, Germany.; Schuster H; Immatics Biotechnologies GmbH, Tübingen, Germany.; Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany.; Wagner C; Immatics Biotechnologies GmbH, Tübingen, Germany.; Rammensee HG; Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany.; Reinhardt C; Immatics Biotechnologies GmbH, Tübingen, Germany.; Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany.; Walter S; Immatics US, Inc., Houston, TX, USA.; Weinschenk T; Immatics Biotechnologies GmbH, Tübingen, Germany.; Luke JJ; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Britten CM; Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Zekri L; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Hagelstein I; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Märklin M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Klimovich B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Christie M; School of Medical Sciences, University of Sydney, 2050 NSW, Australia.; Lindner C; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Kämereit S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Prakash N; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Müller S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Stotz S; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; Maurer A; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.; Greve C; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Schmied B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Atar D; Childrens University Hospital, University Hospital Tübingen, 72076 Tübingen, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Jung G; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.; Department of Immunology, Institute for Cell Biology, Eberhard Karls Universität Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), 72076 Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, 72076 Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, 72076 Tübingen, Germany.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Medici G; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland. gioele.medici@usz.ch.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland. gioele.medici@usz.ch.; Freudenmann LK; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Velz J; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Wang SS; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery and Neurotechnology, Eberhard Karls University Tübingen, Tübingen, Germany.; Kapolou K; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Roche Diagnostics International Ltd, Rotkreuz, Switzerland.; Paramasivam N; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Mühlenbruch L; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Kowalewski DJ; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Vasella F; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Bilich T; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Frey BM; Blood Transfusion Service, Swiss Red Cross, Schlieren, Switzerland.; Dubbelaar ML; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, 72076, Tübingen, Baden-Württemberg, Germany.; Patterson AB; Institute of Immunobiology, Cantonal Hospital St.Gallen, 9007, St. Gallen, Switzerland.; Zeitlberger AM; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland.; Silginer M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Roth P; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Weiss T; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Wirsching HG; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Krayenbühl N; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Bozinov O; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland.; Regli L; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Rushing EJ; Department of Neuropathology, University Hospital and University of Zurich, Schmelzbergstrasse 12, 8091, Zurich, Switzerland.; Sahm F; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Walz JS; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Weller M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Neidert MC; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Wang, S; Freudenmann, L; Kapolou, K; Henschler, R; Bozinov, O; Rammensee, HG; Stefanovic, S; Regli, L; Weller, M; Neidert, M

70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie; 20190512-20190515; Würzburg; DOCV322 /20190508/

Velz J; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Divison of Pediatric Neurosurgery, University Children's Hospital Zurich, Zurich, Switzerland.; Freudenmann LK; Institute of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Medici G; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Dubbelaar M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Mohme M; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Ghasemi DR; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Scheid J; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Kowalewski DJ; Institute of Immunology, University of Tübingen, Tübingen, Germany.; Patterson AB; Institute of Immunobiology, Cantonal Hospital St.Gallen, St. Gallen, Switzerland.; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.; Zeitlberger AM; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.; Lamszus K; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Westphal M; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Eyrich M; Department of Pediatric Haematology, Oncology and Stem Cell Transplantation, University Children's Hospital, University Medical Center, University of Würzburg, Würzburg, Germany.; Messing-Jünger M; Department of Neurosurgery, Asklepios Children's Hospital, Sankt Augustin, Germany.; Röhrig A; Department of Neurosurgery, Asklepios Children's Hospital, Sankt Augustin, Germany.; Reinhard H; Department of Pediatrics, Asklepios Children's Hospital, Sankt Augustin, Germany.; Beccaria K; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cite, Paris, France.; Craveiro RB; Department of Orthodontic, Dental Clinic, University Hospital of RWTH Aachen, Aachen, Germany.; Frey BM; Blood Transfusion Service, Swiss Red Cross, Schlieren, Switzerland.; Sill M; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Nahnsen S; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Department for Computer Science, Biomedical Data Science, University of Tübingen, Tübingen, Germany.; M3 Research Center, University Hospital, Tübingen, Baden- Württemberg, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), Eberhard-Karls University of Tübingen, Tübingen, Baden-Württemberg, Germany.; Gauder M; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Kapolou K; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Silginer M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Weiss T; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Wirsching HG; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Roth P; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Grotzer M; Department of Oncology, University Children's Hospital Zürich, Zürich, Switzerland.; Krayenbühl N; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Divison of Pediatric Neurosurgery, University Children's Hospital Zurich, Zurich, Switzerland.; Bozinov O; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.; Regli L; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Rammensee HG; Institute of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Rushing EJ; Department of Neuropathology, University Hospital and University of Zurich, Zurich, Switzerland.; Sahm F; Department of Neuropathology, Heidelberg University Hospital, and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Walz JS; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Weller M; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Neidert MC; Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. marian.neidert@kssg.ch.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland. marian.neidert@kssg.ch.; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland. marian.neidert@kssg.ch.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Lemke S; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, BW, Germany.; Department of Computer Science, University of Tübingen, Tübingen, BW, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, BW, Germany.; Dubbelaar ML; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, BW, Germany.; Zimmermann P; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, BW, Germany.; Bauer J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, BW, Germany.; Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Hoenisch Gravel N; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Scheid J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, BW, Germany.; Department of Computer Science, University of Tübingen, Tübingen, BW, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, BW, Germany.; Wacker M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Jung S; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, BW, Germany.; Dengler A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Maringer Y; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Rammensee HG; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, BW, Germany.; Institute of Immunology, University of Tübingen, Tübingen, BW, Germany.; Gouttefangeas C; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Institute of Immunology, University of Tübingen, Tübingen, BW, Germany.; Fillinger S; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, BW, Germany.; Bilich T; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Heitmann JS; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, BW, Germany.; Nahnsen S; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, BW, Germany.; Department of Computer Science, University of Tübingen, Tübingen, BW, Germany.; Institute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen, BW, Germany.; M3 Research Center, University Hospital of Tübingen, Tübingen, BW, Germany.; Walz JS; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, BW, Germany juliane.walz@med.uni-tuebingen.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, BW, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, BW, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, BW, Germany.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE